DOJ Indicts Ex-Bristol-Myers Exec For Plavix Deal
Nearly a year after drugmaker Bristol-Myers Squibb Co. agreed to plead guilty to charges stemming from a controversial patent deal over its blood-thinning drug Plavix, the U.S. Department of Justice has...To view the full article, register now.
Already a subscriber? Click here to view full article